BR0016064A - Compostos heterocìclicos e seus sais e uso medicinal dos mesmos - Google Patents

Compostos heterocìclicos e seus sais e uso medicinal dos mesmos

Info

Publication number
BR0016064A
BR0016064A BR0016064-4A BR0016064A BR0016064A BR 0016064 A BR0016064 A BR 0016064A BR 0016064 A BR0016064 A BR 0016064A BR 0016064 A BR0016064 A BR 0016064A
Authority
BR
Brazil
Prior art keywords
agent
hydrogen
action
lower alkyl
salts
Prior art date
Application number
BR0016064-4A
Other languages
English (en)
Inventor
Hiroshi Matsui
Hideo Kobayashi
Satoru Azukizawa
Masayasu Kasai
Akihisa Yoshimi
Hiroaki Shirahase
Original Assignee
Kyoto Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Pharma Ind filed Critical Kyoto Pharma Ind
Publication of BR0016064A publication Critical patent/BR0016064A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

"COMPOSTOS HETEROCìCLICOS E SEUS SAIS E USO MEDICINAL DOS MESMOS". Um composto heterocíclico da fórmula [I] em que R^ 1^ é átomo de hidrogênio ou alquila inferior, R^ 2^ é átomo de hidrogênio, alquila opcionalmente tendo um substituinte e semelhantes, R^ 3^ é átomo de hidrogênio, alquila inferior e semelhantes, A é uma ligação simples ou >N-R^ 5^ em que R^5^ é átomo de hidrogênio ou alquila inferior, B é alquileno inferior, e Y é arila opcionalmente tendo um substituinte e semelhantes, e um seu sal farmaceuticamente aceitável mostram uma ação hipoglicêmica, uma ação hipolipidêmica no sangue, uma ação de melhoramento de resistência à insuluna e uma ação ativadora de PPAR, e são úteis como um agente higoglicêmico, um agente hipolipidêmico, um melhorador de resistência à insulina, um agente terapêutico de diabetes, um agente terapêutico de complicação diabética, um melhorador de tolerância a glicose, um agente de antiaterosclerose, um agente antiobesidade, um agente antiinflamatório, um agente para a profilaxia ou tratamento de doença mediada por PPAR e um agente para a profilaxia ou tratamento de síndrome X.
BR0016064-4A 1999-12-03 2000-11-29 Compostos heterocìclicos e seus sais e uso medicinal dos mesmos BR0016064A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34554399 1999-12-03
JP2000295108 2000-09-27
PCT/JP2000/008464 WO2001040192A1 (fr) 1999-12-03 2000-11-29 Nouveaux composes heterocycliques et sels de ces derniers, utilisations de ces composes en medecine

Publications (1)

Publication Number Publication Date
BR0016064A true BR0016064A (pt) 2004-07-27

Family

ID=26578048

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016064-4A BR0016064A (pt) 1999-12-03 2000-11-29 Compostos heterocìclicos e seus sais e uso medicinal dos mesmos

Country Status (21)

Country Link
US (1) US6589963B2 (pt)
EP (1) EP1236719A4 (pt)
KR (1) KR100716525B1 (pt)
CN (1) CN1215059C (pt)
AR (1) AR033349A1 (pt)
AU (1) AU782631C (pt)
BR (1) BR0016064A (pt)
CA (1) CA2393265A1 (pt)
CO (1) CO5440230A1 (pt)
CZ (1) CZ20021911A3 (pt)
HK (1) HK1053657A1 (pt)
HU (1) HUP0203431A3 (pt)
IL (2) IL149883A0 (pt)
MX (1) MXPA02005528A (pt)
NO (1) NO323922B1 (pt)
NZ (1) NZ519592A (pt)
PL (1) PL356769A1 (pt)
RU (1) RU2256661C2 (pt)
TW (1) TWI286549B (pt)
WO (1) WO2001040192A1 (pt)
YU (1) YU50302A (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
EP1911462A3 (en) 2001-01-26 2011-11-30 Schering Corporation Compositions comprising a sterol absorption inhibitor
RU2299197C2 (ru) 2001-05-29 2007-05-20 Киото Фармасьютикал Индастриз, Лтд. Гетероциклические соединения, фармацевтическая композиция и фармацевтическое средство на их основе и способ лечения
PL367676A1 (en) * 2001-05-29 2005-03-07 Kyoto Pharmaceutical Industries, Ltd. Novel heterocyclic derivatives and medicinal use thereof
AU2003203170A1 (en) * 2002-01-17 2003-07-30 Takeda Chemical Industries, Ltd. Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof
DE10222034A1 (de) * 2002-05-17 2003-11-27 Bayer Ag Tetrahydroisochinolin-Derivate
PA8594401A1 (es) * 2003-02-21 2004-09-16 Pfizer Acidos carboxilicos de heteroarilo condensado como agonista del ppar
CN1300115C (zh) * 2004-03-26 2007-02-14 厦门大学 一种合成1，2，3，4－四氢异喹啉衍生物的方法
ES2682282T3 (es) 2004-10-29 2018-09-19 Kalypsys, Inc. Compuestos bicíclicos sustituidos con sulfonilo como moduladores de PPAR
US7790745B2 (en) 2005-10-21 2010-09-07 Bristol-Myers Squibb Company Tetrahydroisoquinoline LXR Modulators
AU2006305769B2 (en) * 2005-10-25 2012-06-14 Kalypsys, Inc. Salts of modulators of PPAR and methods of treating metabolic disorders
WO2008091863A1 (en) 2007-01-23 2008-07-31 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
US20080186971A1 (en) * 2007-02-02 2008-08-07 Tarari, Inc. Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
WO2009019598A2 (en) * 2007-08-03 2009-02-12 Dr. Reddy's Laboratories Ltd. Inhalation therapy for respiratory disorders
CA2716664C (en) * 2008-03-07 2016-10-11 Transtech Pharma, Inc. Oxadiazoanthracene compounds
AR080374A1 (es) 2010-03-05 2012-04-04 Sanofi Aventis Procedimiento para la preparcion de 2-(ciclohexilmetil)-n-(2-((2s)-1-metilpirrolidin-2-il) etil)- 1,2,3,4-tetrahidroisoquinolin-7- sulfonamida
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
WO2012033195A1 (ja) * 2010-09-10 2012-03-15 京都薬品工業株式会社 複素環化合物
CN102807526B (zh) * 2011-06-21 2015-12-02 寿光富康制药有限公司 组蛋白去乙酰化酶抑制剂ZYJ-D08a及其差向异构体的制备方法与应用
CN102702098A (zh) * 2012-05-24 2012-10-03 盛世泰科生物医药技术(苏州)有限公司 6-甲氧基-1,2,3,4四氢喹啉-5羧酸甲酯的合成
AR101196A1 (es) * 2014-07-16 2016-11-30 Gruenenthal Gmbh Compuestos de pirimidina sustituidos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051189A (ja) 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
AR240698A1 (es) 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
ES2137915T3 (es) 1987-09-04 2000-01-01 Beecham Group Plc Derivados de tiazolidindiona sustituida.
US5246943A (en) * 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
ATE277907T1 (de) 1996-07-01 2004-10-15 Lilly Co Eli Blutzuckersenkende und lipidsenkende verbindungen
WO1998000137A1 (en) * 1996-07-01 1998-01-08 Eli Lilly And Company Hypoglycemic and hypolipidemic compounds

Also Published As

Publication number Publication date
YU50302A (sh) 2006-01-16
KR20020058079A (ko) 2002-07-12
US20030027836A1 (en) 2003-02-06
IL149883A0 (en) 2002-11-10
AR033349A1 (es) 2003-12-17
HK1053657A1 (en) 2003-10-31
WO2001040192A1 (fr) 2001-06-07
NO20022600D0 (no) 2002-05-31
EP1236719A1 (en) 2002-09-04
MXPA02005528A (es) 2002-09-02
CN1402712A (zh) 2003-03-12
CZ20021911A3 (cs) 2002-10-16
KR100716525B1 (ko) 2007-05-10
HUP0203431A2 (hu) 2003-02-28
AU1649501A (en) 2001-06-12
AU782631B2 (en) 2005-08-18
NO323922B1 (no) 2007-07-23
NO20022600L (no) 2002-08-05
IL149883A (en) 2007-03-08
RU2256661C2 (ru) 2005-07-20
CN1215059C (zh) 2005-08-17
US6589963B2 (en) 2003-07-08
PL356769A1 (en) 2004-07-12
HUP0203431A3 (en) 2003-11-28
TWI286549B (en) 2007-09-11
CO5440230A1 (es) 2004-09-30
CA2393265A1 (en) 2001-06-07
AU782631C (en) 2006-08-17
EP1236719A4 (en) 2003-06-25
NZ519592A (en) 2003-11-28

Similar Documents

Publication Publication Date Title
BR0016064A (pt) Compostos heterocìclicos e seus sais e uso medicinal dos mesmos
TR200102805T2 (tr) Glikokinaz aktivatörleri
BR0017050A (pt) Oxazolidinonas suebstituìdas e seu emprego na área da coagulação do sangue
ES8705886A1 (es) Un metodo para preparar un derivadode tiazolidin-diona
KR940019699A (ko) 옥사졸리딘디온 유도체, 그의 제조방법 및 용도
BR0014179A (pt) Modernos derivados de ácido aminodicarboxìlico com propriedades farmacêuticas
RU2001131722A (ru) 5-[4-(6-Метокси-1-метил-1Н-бензимидазол-2-илметокси)бензил]-тиазолидин-2,4 -ди он гидрохлорид, обладающий гипогликемической активностью
BRPI0407506A (pt) compostos para o tratamento de distúrbios metabólicos, seu uso e composição farmacêutica compreendendo os mesmos
AR025449A1 (es) Soluciones farmaceuticas de levosimendan
RU2005135441A (ru) Соединения для лечения метаболических расстройств
AR043259A1 (es) Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello
WO2002030867A3 (en) Drugs for diabetes
KR970025615A (ko) 암 전이 억제제
EP1122255A4 (en) CARBONIC ACID DERIVATIVES AND MEDICINES THAT CONTAIN THEM AS ACTIVE INGREDIENTS
BR0306880A (pt) Derivados do ácido fenil(alquil)carboxìlico e derivados diÈnicos de fenilalquila heterocìclica e o uso dos mesmos como medicamentos com atividade de redução de glicose do soro e/ou de lipìdios no soro
KR940702491A (ko) 옥사졸리돈 유도체
MXPA04007183A (es) Composicion farmaceutica para el control de la glucosa en sangre de pacientes con diabetes tipo 2.
BR0111199A (pt) Compostos heterocìclicos
BR0209735A (pt) Derivados heterocìclicos e uso medicinal destes
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
KR890003378A (ko) 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물
EP0256856A3 (en) A parenterally administrable composition
JP2001039976A5 (pt)
AU6432899A (en) Use of metformin to counteract weight gain associated with valproate and other psychotropic medications

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8,11,13,24 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.